Editas Medicine Profit Margin 2015-2021 | EDIT
Current and historical gross margin, operating margin and net profit margin for Editas Medicine (EDIT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Editas Medicine net profit margin as of September 30, 2021 is -871.91%.
|Editas Medicine Annual Profit Margins
|Editas Medicine Quarterly Profit Margins
||Medical - Biomedical and Genetics
Editas Medicine, Inc. is a genome editing company. It focuses on translating its genome editing technology into a novel class of human therapeutics which enable precise and corrective molecular modification to treat diseases. Editas Medicine, Inc. is based in Cambridge, Massachusetts.